Skip to main content
. 2018 Apr 5;13(4):e0195464. doi: 10.1371/journal.pone.0195464

Table 2. Responses to antithyroid drugs and serum s(P)RR in patients with Graves’ disease.

NR group R group Total
Serum s(P)RR levels ≥ 27 ng/ml 11 10 21
Serum s(P)RR levels < 27 ng/ml 2 8 10
13 18 31
RR: 2.63

s(P)RR, soluble (pro)renin receptor; NR, non-responder; R, responder; RR, Relative Risk